MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Abnormal fractional anisotropy of the tremor network in tremor dominant Parkinson’s disease and Essential tremor plus syndrome

    P. Pal, S. Prasad, R. Bharath, J. Saini (Bangalore, India)

    Objective: To evaluate alterations in fractional anisotropy (FA) of the basal ganglia-thalamocortical (BGTC) and cerebello-thalamocortical (CTC) network in tremor dominant Parkinson’s disease (TDPD) and essential…
  • 2022 International Congress

    Predictive factors for a favorable STN-DBS outcome in Parkinson’s Disease: the role of axial symptoms

    C. Ledda, C. Artusi, G. Imbalzano, M. Bozzali, M. Rizzone, A. Romagnolo, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: We sought to identify and weight clinical and demographic factors predicting bilateral STN-DBS outcomes. Background: DBS is an established therapeutic option for treating PD…
  • 2022 International Congress

    A systematic review on physical health education interventions for people with Parkinson’s: content, impact and implementation considerations across Parkinson’s trajectory

    L. Alushi, J. Alexander, J. Jones (Cambridge, United Kingdom)

    Objective: To examine the content of education interventions that promote physical activity (PA) behavior in PwP, and to assess their effectiveness on physical and psychosocial…
  • 2022 International Congress

    Determination of glycine transporter 1 levels with [3H]-NFPS binding in hemi-parkinsonian rats with L-DOPA induced dyskinesia

    I. Frouni, D. Bédard, E. Kim, S. Belliveau, C. Kwan, P. Huot (Montreal, Canada)

    Objective: To determine the distribution of the glycine transporter 1 (GlyT1) in brain areas implicated in parkinsonism and L-3,4-dihydroxyphenylalanine (L-DOPA) induced dyskinesia in the 6-hydroxydopamine…
  • 2022 International Congress

    Characterization of nociplastic pains in Parkinson’s disease (PD) with the PD pain classification system (PD-PCS)

    V. Mylius, S. Lloret, N. Fisch, R. Gonzenbach, G. Kägi, J. Möller, F. Brugger, D. de Andrade (Valens, Switzerland)

    Objective: To describe the new category of nociplastic pain (NP). We defined Parkinson's disease (PD)-related pains and allocated them to a mechanistic category by using the…
  • 2022 International Congress

    Response of freezing, posture and voice to increasing levodopa doses in Parkinson’s disease

    G. Imbalzano, D. Rinaldi, G. Calandra Buonaura, M. Contin, F. Amato, G. Giannini, L. Sambati, C. Ledda, A. Romagnolo, G. Olmo, P. Cortelli, M. Zibetti, C. Artusi, L. Lopiano (Torino, Italy)

    Objective: To analyze the resistance to high levodopa doses of FoG, posture, speech, and gait features in PD patients during a daily-ON therapeutic condition. Background:…
  • 2022 International Congress

    Computerized assessment of handwriting in Parkinson’s disease and its relation to motor symptoms

    L. Diaz-Feliz, P. Sanz-Cartagena, M. Faundez-Zanuy, JM. Arbelo, P. García-Ruiz (Madrid, Spain)

    Objective: Computerized assessment of dysgraphia in PD de novo patients and correlation with UPDRS III. Background: Dysgraphia is a well-known motor symptom of PD, but…
  • 2022 International Congress

    TWO-YEAR LONGITUDINAL FOLLOW-UP OF VISUAL ILLUSIONS AND HALLUCINATIONS IN PARKINSON’S DISEASE

    S. Beze, L. Castellani, B. Pereira, F. Chiambaretta, F. Durif, A. Marques (Clermont-Ferrand, France)

    Objective: To determine whether visual illusions (VI) evolve towards visual hallucinations (VH) along the time in Parkinson’s disease (PD), and whether ophthalmological treatment may have…
  • 2022 International Congress

    Effect of freezing of gait and antiparkinsonian medication on joint kinematics and kinetics in gait in patients with Parkinson’s disease

    T. Shida, D. Campos, C. Oliveira, R. Treza, S. Hondo, E. Los Angeles, C. Bernardo, L. Oliveira, M. Carvalho, D. Coelho (São Bernardo Campo, Brazil)

    Objective: This study aims to evaluate the interaction between FoG and antiparkinsonian medication on individuals with PD's kinematic and kinetic gait parameters. Background: Regarding Parkinson's…
  • 2022 International Congress

    Lower-limb dystonia as an explanation for freezing of gait responsive to cueing in Parkinson’s Disease

    M. Dias, M. Soares (Lisbon, Portugal)

    Objective: We aimed to search the literature for a potential association between freezing of gait (FOG) with cueing and dystonia with sensory tricks in Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 206
  • 207
  • 208
  • 209
  • 210
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley